vs

Side-by-side financial comparison of COMERICA INC (CMA) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

COMERICA INC is the larger business by last-quarter revenue ($838.0M vs $719.4M, roughly 1.2× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 21.0%, a 52.2% gap on every dollar of revenue. On growth, COMERICA INC posted the faster year-over-year revenue change (3.3% vs 3.1%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs 8.9%).

Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CMA vs DOC — Head-to-Head

Bigger by revenue
CMA
CMA
1.2× larger
CMA
$838.0M
$719.4M
DOC
Growing faster (revenue YoY)
CMA
CMA
+0.3% gap
CMA
3.3%
3.1%
DOC
Higher net margin
DOC
DOC
52.2% more per $
DOC
73.2%
21.0%
CMA
Faster 2-yr revenue CAGR
CMA
CMA
Annualised
CMA
108.9%
8.9%
DOC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CMA
CMA
DOC
DOC
Revenue
$838.0M
$719.4M
Net Profit
$176.0M
$114.0M
Gross Margin
Operating Margin
17.4%
Net Margin
21.0%
73.2%
Revenue YoY
3.3%
3.1%
Net Profit YoY
-4.3%
2406.4%
EPS (diluted)
$1.35
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMA
CMA
DOC
DOC
Q4 25
$719.4M
Q3 25
$838.0M
$705.9M
Q2 25
$849.0M
$694.3M
Q1 25
$829.0M
$702.9M
Q4 24
$825.0M
$698.0M
Q3 24
$811.0M
$700.4M
Q2 24
$824.0M
$695.5M
Q1 24
$784.0M
$606.6M
Net Profit
CMA
CMA
DOC
DOC
Q4 25
$114.0M
Q3 25
$176.0M
$-117.1M
Q2 25
$199.0M
$31.7M
Q1 25
$172.0M
$42.8M
Q4 24
$170.0M
$4.5M
Q3 24
$184.0M
$85.9M
Q2 24
$206.0M
$146.0M
Q1 24
$138.0M
$6.7M
Gross Margin
CMA
CMA
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
CMA
CMA
DOC
DOC
Q4 25
17.4%
Q3 25
9.2%
Q2 25
5.7%
Q1 25
7.7%
Q4 24
-2.2%
Q3 24
14.1%
Q2 24
22.3%
Q1 24
3.7%
Net Margin
CMA
CMA
DOC
DOC
Q4 25
73.2%
Q3 25
21.0%
-16.6%
Q2 25
23.4%
4.6%
Q1 25
20.7%
6.1%
Q4 24
20.6%
0.7%
Q3 24
22.7%
12.3%
Q2 24
25.0%
21.0%
Q1 24
17.6%
1.1%
EPS (diluted)
CMA
CMA
DOC
DOC
Q4 25
$0.16
Q3 25
$1.35
$-0.17
Q2 25
$1.42
$0.05
Q1 25
$1.25
$0.06
Q4 24
$1.22
$0.02
Q3 24
$1.33
$0.12
Q2 24
$1.49
$0.21
Q1 24
$0.98
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMA
CMA
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$5.4B
$9.8B
Stockholders' EquityBook value
$7.4B
$7.5B
Total Assets
$77.4B
$20.3B
Debt / EquityLower = less leverage
0.73×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMA
CMA
DOC
DOC
Q4 25
$467.5M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$119.8M
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
CMA
CMA
DOC
DOC
Q4 25
$9.8B
Q3 25
$5.4B
$9.1B
Q2 25
$5.8B
$9.0B
Q1 25
$5.7B
$8.9B
Q4 24
$6.7B
$8.7B
Q3 24
$6.8B
$8.6B
Q2 24
$7.1B
$8.6B
Q1 24
$7.1B
$8.8B
Stockholders' Equity
CMA
CMA
DOC
DOC
Q4 25
$7.5B
Q3 25
$7.4B
$7.6B
Q2 25
$6.9B
$7.9B
Q1 25
$7.1B
$8.2B
Q4 24
$6.5B
$8.4B
Q3 24
$7.4B
$8.6B
Q2 24
$6.2B
$8.8B
Q1 24
$6.0B
$8.9B
Total Assets
CMA
CMA
DOC
DOC
Q4 25
$20.3B
Q3 25
$77.4B
$19.6B
Q2 25
$78.0B
$19.8B
Q1 25
$77.6B
$19.8B
Q4 24
$79.3B
$19.9B
Q3 24
$79.7B
$20.0B
Q2 24
$79.6B
$20.2B
Q1 24
$79.4B
$20.5B
Debt / Equity
CMA
CMA
DOC
DOC
Q4 25
1.31×
Q3 25
0.73×
1.20×
Q2 25
0.84×
1.14×
Q1 25
0.81×
1.08×
Q4 24
1.02×
1.04×
Q3 24
0.92×
1.00×
Q2 24
1.15×
0.98×
Q1 24
1.18×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMA
CMA
DOC
DOC
Operating Cash FlowLast quarter
$-270.0M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
-1.53×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMA
CMA
DOC
DOC
Q4 25
$1.3B
Q3 25
$-270.0M
$315.0M
Q2 25
$476.0M
$363.5M
Q1 25
$273.0M
$279.4M
Q4 24
$601.0M
$1.1B
Q3 24
$1.0B
$318.2M
Q2 24
$111.0M
$316.2M
Q1 24
$-205.0M
$152.6M
Free Cash Flow
CMA
CMA
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
FCF Margin
CMA
CMA
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
Capex Intensity
CMA
CMA
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
Cash Conversion
CMA
CMA
DOC
DOC
Q4 25
10.99×
Q3 25
-1.53×
Q2 25
2.39×
11.48×
Q1 25
1.59×
6.52×
Q4 24
3.54×
235.43×
Q3 24
5.70×
3.71×
Q2 24
0.54×
2.17×
Q1 24
-1.49×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons